Search Results

1 - 10 of 599 items :

  • "dissolution" x
Clear All

Abstract

In creating his Psychophysiological Theory, Jan Mazurkiewicz transplanted John Hughlings Jackson’s method into the field of psychiatry. Like his precursor, he distinguished four evolutionary levels, but this time with regard to mental activity. According to Mazurkiewicz’s approach, disease is the reverse of evolution. Doing damage to the highest evolutionary level, it allows evolutionarily lower levels to take control of the patient’s psyche. Distorted by the etiological factor, the lower mental levels manifest as mental disease. In his Psychophysiological Theory, Mazurkiewicz distinguishes three types of dissolution: intra-level dissolution (psychoneuroses), slow dissolution or dissociation proper (schizophrenia), and rapid, delirium-like dissolution (impaired consciousness). Kaczyński noted that, based on an in-depth analysis of the phylogenetic and ontogenetic development of the successive evolutionary levels of the nervous system, Mazurkiewicz transposed the principles of the Jacksonian concept of hierarchical evolution – dissolution. Within a dozen or so years from birth to maturity, the process of evolution of mankind is recapitulated, with the speed of lightning, in an individual – from instincts, which are phylogenetically the oldest, to the highest functions of the frontal lobes. The present paper makes mention of research conducted at Lublin’s Department of Psychiatry which expands on Mazurkiewicz’s theory.

REFERENCES 1. M. Wesoły, K. Cal, P. Ciosek and W. Wróblewski, Influence of dissolution-modifying excipients in various pharmaceutical formulations on electronic tongue results, Talanta 162 (2017) 203–209; https://doi.org/10.1016/j.talanta.2016.10.018 2. A. Nokhodchi, C. M. Hentzschel and C. S. Leopold, Drug release from liquisolid systems: speed it up, slow it down, Expert Opin. Drug Deliv. 8 (2011) 191–205; https://doi.org/10.1517/17425247.2011.548801 3. L. Azharshekoufeh, J. Shokri, M. B. Jalali and Y. Javadzadeh, Liquigroud technique: a new concept for

1 Introduction The solid-state dissolution processes are a subject of continuous research attempts whose results are of interest both for basic knowledge and for applications. Gained data extend the knowledge about fundamental processes of environmental geology and engineering. Acquired knowledge is widely applied in different areas of industry where passivation, corrosion or ablation are involved. Conventional methods employed in the solid-state dissolution investigations, which are based on measurements of instantaneous ion concentration changes of the solution

References A. Rajendarn and S. K. Basu, Crystal modification of dipyridamole using different solvents and crystallization conditions, Int. J. Pharm.   321 (2006) 27-34; DOI: 10.1016/J.IJPHARM.2006.04.021. N. Blagden, M. de Matas, P. T. Gavan and P. York, Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates, Adv. Drug Del. Rev.   59 (2007) 617-630; DOI: 10.1016/J.ADDR.2007.05.011. S. R. Byrn, R. R. Pfeiffer, G. Stephenson, D. J. W. Grant and W. B. Gleason, Solid state pharmaceutical chemistry, Chem. Mater.   6

References V. Stella and R. Rajewski, Cyclodextrins: Their future in drug formulation and delivery, Pharm. Res. 14 (1997) 556-567. A. Latrofa, G. Trapani, M. Franco, M. Serra, M. Muggironi, F. P. Fanizzi, A. Cutrignelli and G. Liso, Complexation of phenytoin with some hydrophilic cyclodextrins effect on aqueous solubility, dissolution rate and anticonvulsant activity in mice, Eur. J. Pharm. Biopharm. 52 (2001) 65-73. C. W. Park, S. J. Kim, S. J. Park, J. H. Kim, J. K. Kim, G. B. Park, J. O. Kim and Y. I. Ha, Inclusion complexes of conjugated linoleic acid

REFERENCES 1. United States Pharmacopoeia 38 – National Formulary 33 , USP Convention, Rockville (MD) 2015, p. 3869. 2. S. Klein, The use of biorelevant dissolution media to forecast the in vivo performance of a drug, AAPS. J. 12 (2010) 397–406; DOI: 10.1208/s12248-010-9203-3. 3. Y. Qiu, Y. Chen, G. Zhang and W. Porter, Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice , Academic Press, London 2009, p. 411. 4. Sirius Analytical Instruments Ltd., New instrument for automated biorelevant biphasic dissolution and solubility testing, Eur

References 1. Azarmi S. et al.: Current perspectives in dissolution testing of conventional and novel dosage forms. Int. J. Pharm., 328(1), 12, 2007. 2. Babar A., Fares H. M., Plakogiannis F. M.: In vitro release of testosterone from suppository bases and in vivo absorption studies in human males. J. Pharm. Sci., 82(4), 389, 1993. 3. Beral V., Bull D., Reeves G.: Endometrial cancer and hormonereplacement therapy in the Million Women Study. Lancet, 365, 1543, 2005. 4. Bergogne-Bérézin E., Bryskier A.: The suppository form of antibiotic administration

. J. Smillie, W. Mabusela, J. Syce, Q. Johnson, W. Folk and I. A. Khan, Flavonol glycosides from the South African medicinal plant Sutherlandia frutescens, Planta Med. 76 (2010) 178-181; DOI: 10.1055/s-0029-1186030. 5. P. Jin, S. Madieh and L. L. Augsburgers, Challenges with dissolution testing and quality assessment for commercial feverfew products, Dissolut. Technol. (2007) 14-20; DOI: 10.14227/DT140307P14. 6. G. Gabriels, M. Lambert, P. Smith and D. Hiss, Will the new Consumer Protection Act prevent harm to nutritional supplement users?, S. Afr. Med. J. 101 (2011

References V. A. Saharan, V. Kukkar, M. Kataria, V. Kharb and P. Choudhury, Ordered mixing: mechanism, process and applications in pharmaceutical formulations, Asian J. Pharm. Sci.   3 (2008) 240-259. V. A. Saharan, M. Kataria, V. Kukkar, M. Gera and P. K. Choudhury, Dissolution enhancement of drugs Part II: Effect of carriers, Int. J. Health Res.   2 (2009) 207-223. V. A. Saharan, M. Kataria, V. Kukkar, M. Gera and P. K. Choudhury, Dissolution enhancement of drugs Part I: Technologies and effect of carriers, Int. J. Health Res.   2 (2009) 107-124. C. M

. (2010). Electrooxidation of ethanol at polycrystalline and platinum stepped single crystals: A study by differential electrochemical mass spectrometry. Electrochim. Acta 55, 7951–7960. DOI: 10.1016/j.electacta.2010.04.008. 11. Pierozynski, B. (2012). Kinetic aspects of ethanol electrooxidation on catalytic surfaces of Pt in 0.5 M H 2 SO 4 . Int. J. Electrochem. Sci. 7, 3327–3338. 12. Topalov, A.A., Cherevko, S., Zeradjanin, A.R., Meier, J.C., Katsounaros, I. & Mayrhofer, K.J.J. (2014). Towards a comprehensive understanding of platinum dissolution in acidic media